Systemic adverse events from inhaled corticosteroids self-reported by asthma patients: A ‘‘real-life’’ cross sectional study
Fuente:
Redalyc
Saved in:
| Main Author: | C. R. Pinto |
|---|---|
| Format: | Artículo científico |
| Language: | en |
| Published: |
Sociedade Portuguesa de Pneumologia
2016
|
| Subjects: | |
| Online Access: | |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
Dangers of under‐treatment and over‐treatment with inhaled corticosteroids in children with asthma
by: Breanne Hayes, et al.
Published: (2024)
by: Breanne Hayes, et al.
Published: (2024)
Are Sudanese community pharmacists capable to prescribe and demonstrate asthma inhaler devices to patrons? A mystery patient study
by: Abuzar OSMAN
Published: (2012)
by: Abuzar OSMAN
Published: (2012)
Outpatient inhaled corticosteroid use in bronchopulmonary dysplasia
by: Cynara Leon, et al.
Published: (2024)
by: Cynara Leon, et al.
Published: (2024)
A cross‐sectional analysis of medications used by patients reporting alopecia areata on the FDA adverse events reporting system
by: Advaitaa Ravipati, et al.
Published: (2024)
by: Advaitaa Ravipati, et al.
Published: (2024)
Omalizumab: a treatment for severe asthma in real life?
by: Anaïs Briquet
Published: (2015)
by: Anaïs Briquet
Published: (2015)
Urine metabolomics signature reveals novel determinants of adrenal suppression in children taking inhaled corticosteroids to control asthma symptoms
by: Dung T. Tran, et al.
Published: (2024)
by: Dung T. Tran, et al.
Published: (2024)
Obstructive sleep apnea prevalence and adverse respiratory events in surgical patients
by: R. Reis
Published: (2014)
by: R. Reis
Published: (2014)
Prevalence and associated factors for asthma in adults in Quito: a cross-sectional study
by: Angelita Cabrera
Published: (2022)
by: Angelita Cabrera
Published: (2022)
Barriers to reporting of adverse drugs reactions: a cross sectional study among community pharmacists in United Kingdom
by: Ejaz Cheema
Published: (2017)
by: Ejaz Cheema
Published: (2017)
Inter-professional education unveiling significant association between asthma knowledge and inhaler technique
by: Iman A. BASHETI
Published: (2016)
by: Iman A. BASHETI
Published: (2016)
Pregnancy and health-related quality of life: A cross sectional study
by: Robinson Ramírez-Vélez
Published: (2011)
by: Robinson Ramírez-Vélez
Published: (2011)
Reply to ‘‘Obstructive sleep apnea prevalence and adverse respiratory events in surgical patients’’
by: Helder Pereira
Published: (2014)
by: Helder Pereira
Published: (2014)
Risk factors of self-reported adverse drug events among Medicare enrollees before and after Medicare Part D
by: Olayinka O. SHIYANBOLA
Published: (2009)
by: Olayinka O. SHIYANBOLA
Published: (2009)
Real-life efficacy and safety of omalizumab in Portuguese patients with persistent uncontrolled asthma
by: M. Pereira Barbosa
Published: (2015)
by: M. Pereira Barbosa
Published: (2015)
Response to imatinib in patient with corticosteroid-unresponsive idiopatic hypereosinophilic syndrome
by: I. Yilmaz
Published: (2016)
by: I. Yilmaz
Published: (2016)
Self-reported and actual involvement of community pharmacists in patient counseling: a cross-sectional and simulated patient study in Gondar, Ethiopia
by: Abdrrahman S. Surur
Published: (2017)
by: Abdrrahman S. Surur
Published: (2017)
Association between sedation and adverse events in intensive care patients
by: Taís Pagliuco Barbosa
Published: (2018)
by: Taís Pagliuco Barbosa
Published: (2018)
Understanding patient adherence to inhaled medication: The social representations of COPD
by: A. Duarte-de-Araújo
Published: (2017)
by: A. Duarte-de-Araújo
Published: (2017)
Inhaled corticosteroid response in youth with asthma and history of child maltreatment
by: Kristina Gaietto, et al.
Published: (2024)
by: Kristina Gaietto, et al.
Published: (2024)
Insights into hair dye use and self‐reported adverse skin reactions in the Dutch general population: A cross‐sectional questionnaire‐based study
by: Fieke M. Rosenberg, et al.
Published: (2024)
by: Fieke M. Rosenberg, et al.
Published: (2024)
AZD0449, an inhaled JAK1 inhibitor, in healthy participants and patients with mild asthma
by: Anna Lundahl, et al.
Published: (2025)
by: Anna Lundahl, et al.
Published: (2025)
Autoimmune hemolytic anemia, adverse event to venetoclax
by: Carmen Carriles-Fernández
Published: (2019)
by: Carmen Carriles-Fernández
Published: (2019)
Transparency in adverse event reporting
by: Abi Seager
Published: (2025)
by: Abi Seager
Published: (2025)
Erratum to ‘‘Compliance with inhalation therapy in patients with chronic obstructive pulmonary disease’’
by: F. Represas-Carrera
Published: (2015)
by: F. Represas-Carrera
Published: (2015)
Estimating the effect of diuretics and inhaled corticosteroids for evolving bronchopulmonary dysplasia in preterm infants
by: Jonathan L. Slaughter, et al.
Published: (2024)
by: Jonathan L. Slaughter, et al.
Published: (2024)
Asthma outcomes, inhaled corticosteroid adherence and socio‐economic deprivation in English regions
by: Haania Hussain, et al.
Published: (2024)
by: Haania Hussain, et al.
Published: (2024)
Quality of the record of drug-related problems in a database for voluntary adverse event reporting
by: María Teresa Aznar-Saliente
Published: (2017)
by: María Teresa Aznar-Saliente
Published: (2017)
Association between corticosteroid use and fracture risk in children with asthma: A nationwide cohort study
by: Hyunmin Ji, et al.
Published: (2025)
by: Hyunmin Ji, et al.
Published: (2025)
Depression among smokers of a web-based intervention to quit smoking: a cross-sectional study
by: Henrique Pinto Gomide
Published: (2017)
by: Henrique Pinto Gomide
Published: (2017)
Atezolizumab-induced encephalitis in a patient with metastatic breast cancer: a case report and review of neurological adverse events associated with checkpoint inhibitors
by: Rita Nader
Published: (2021)
by: Rita Nader
Published: (2021)
Higher prevalence of dupilumab‐induced ocular adverse events in atopic dermatitis compared to asthma: A daily practice analysis
by: Anne R. Schlösser, et al.
Published: (2024)
by: Anne R. Schlösser, et al.
Published: (2024)
Analysis of publicly available adverse events reported for pediatric patients treated with Janus kinase inhibitors
by: Sahithi Talasila, et al.
Published: (2024)
by: Sahithi Talasila, et al.
Published: (2024)
Detecting adverse drug events during the hospital stay
by: C. Berga Culleré
Published: (2009)
by: C. Berga Culleré
Published: (2009)
Factors associated with quality of life among community pharmacists in Lebanon: results of a cross-sectional study
by: Hala Sacre
Published: (2019)
by: Hala Sacre
Published: (2019)
Characteristics of infectious endocarditis patients from a town in Boyacá. A cross-sectional study
by: Javier Orlando Barón-Barón
Published: (2020)
by: Javier Orlando Barón-Barón
Published: (2020)
Systemic reactions to house dust mite subcutaneous immunotherapy in patients with allergic rhinitis and/or asthma: A real‐life, multi‐center study
by: Qingxiu Xu, et al.
Published: (2024)
by: Qingxiu Xu, et al.
Published: (2024)
Compliance to treatment in diabetic patients from Bucaramanga, Colombia: a cross sectional study
by: Juan Manuel Ospina Díaz
Published: (2019)
by: Juan Manuel Ospina Díaz
Published: (2019)
Prescription and application adequacy of topical corticosteroids based on the finger‐tip unit method in adult patients with atopic dermatitis: A cross‐sectional study
by: Fumi Matsuki, et al.
Published: (2025)
by: Fumi Matsuki, et al.
Published: (2025)
Airway burn or inhalation injury: should all patients be intubated?
by: Yuliana A. Orozco-Peláez
Published: (2018)
by: Yuliana A. Orozco-Peláez
Published: (2018)
Cost-effectiveness of budesonide-formoterol in maintenance therapy of asthma patients
by: María C. Cano Salas
Published: (2024)
by: María C. Cano Salas
Published: (2024)
Similar Items
-
Dangers of under‐treatment and over‐treatment with inhaled corticosteroids in children with asthma
by: Breanne Hayes, et al.
Published: (2024) -
Are Sudanese community pharmacists capable to prescribe and demonstrate asthma inhaler devices to patrons? A mystery patient study
by: Abuzar OSMAN
Published: (2012) -
Outpatient inhaled corticosteroid use in bronchopulmonary dysplasia
by: Cynara Leon, et al.
Published: (2024) -
A cross‐sectional analysis of medications used by patients reporting alopecia areata on the FDA adverse events reporting system
by: Advaitaa Ravipati, et al.
Published: (2024) -
Omalizumab: a treatment for severe asthma in real life?
by: Anaïs Briquet
Published: (2015)